Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and ...

Artificial Intelligence (AI)-driven gene sequencing, undertaken by the Department of Biotechnology (DBT) in Govt of India, promises to power India’s transition toward “personalised” medical ...

The Minister said India’s next priority is to transition AI in biotechnology from proof-of-concept research into scalable, industry-ready solutions through partnerships supported by BIRAC.

The Precision Medicine Market represents a transformative shift in global healthcare, focusing on tailoring medical treatment ...

Study identified numerous influential “hub genes” that offer promising new targets for early detection and therapeutic intervention.

Allied Market Research published a report, titled, "Genotyping Market by Product (Instruments, Reagents and Kits and Software ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...

"Medical Genomics" research group at ISTA "Data Science, Machine Learning, and Information Theory" research group at ISTA Al ...

New @hopkinskimmel research finds extra copies of chromosome 1q may drive the earliest stages of pancreatic cancer. › ...

Iberdomide has the potential to be the first approved CELMoD agentThe U.S. FDA has granted Breakthrough Therapy Designation and Priority Review for this indication and assigned a target action date of ...

The FDA accepted the new drug application for iberdomide based on minimal residual disease negativity benefit shown in the ...